Toronto Dominion Bank
KRTX

Toronto Dominion Bank’s Karuna Therapeutics, Inc. Common Stock KRTX Stock Holding History

Toronto Dominion Bank’s Portfolio KRTX Stock Details KRTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-40
Closed -$9K – 1923
2023
Q2 		$9K Buy
+40
New +$8.57K ﹤0.01% 1300
2022
Q1 		– Sell
-12,397
Closed -$1.62M – 2134
2021
Q4 		$1.62M Buy
+12,397
New +$1.6M ﹤0.01% 893

Other funds holding KRTX

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
SI
Sofinnova Investments Menlo Park, California $2.63B AUM 117.41% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return
GA
General Atlantic New York $2.15B AUM 35.02% 1-Year Est. Return

Toronto Dominion Bank's KRTX Position: Q3 2023 in Review

Toronto Dominion Bank sold out of Karuna Therapeutics, Inc. Common Stock (KRTX) in Q3 2023, closing a stake of 40 shares — an estimated $9K sold.

Toronto Dominion Bank first reported a position in KRTX in Q4 2021 and held it in 2 quarters. The position peaked at $1.62M in Q4 2021. 256 funds tracked by Wall St. Rank hold KRTX as of Q3 2023.

  • Toronto Dominion Bank reported no remaining Karuna Therapeutics, Inc. Common Stock position as of Q3 2023 after selling out during the quarter.
  • Toronto Dominion Bank sold 40 Karuna Therapeutics, Inc. Common Stock shares in Q3 2023, an estimated $9K.
  • Toronto Dominion Bank first reported a position in Karuna Therapeutics, Inc. Common Stock in Q4 2021 and held it in 2 quarters.
  • Toronto Dominion Bank's Karuna Therapeutics, Inc. Common Stock position peaked at $1.62M in Q4 2021.
  • 256 funds tracked by Wall St. Rank held Karuna Therapeutics, Inc. Common Stock as of Q3 2023.

Based on Toronto Dominion Bank's 13F filing for Q3 2023, filed 14 Nov 2023.